The Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) is a collaboration of leading scientists from UCLA, Charles R. Drew University, Friends Research Institute, and RAND Corporation. CHIPTS' research agenda incorporates advances in HIV prevention science using combination antiretroviral therapy for those living with HIV and prophylactic antiretrovirals (ARVs) for high-risk HIV-negative individuals. Yet in key populations (e.g., young MSM of color, transgender, homeless, incarcerated, African American women), especially those with concurrent substance use and mental health disorders, barriers prevent access and adherence required to benefit from ARVs. CHIPTS will bridge these gaps with a plan to promote research, dissemination and training on treatment as prevention (TasP) in HIV-positive individuals and HIV prevention that integrates ARVs for high-risk, HIV-negative individuals (pre-exposure prophylaxis, PrEP), with emphasis on those with substance use and mental health disorders. CHIPTS has three specific aims. (1) SCIENCE: To promote novel, high impact and transformational research to eliminate barriers and to increase uptake, adherence, and persistence across the HIV prevention, care and policy continua. We study behavioral, biomedical, technological and structural approaches at individual, family, community, and policy impact levels that will stop new HIV infections, particularly in key populations. (2) NETWORKING: To sponsor meetings and provide venues for collaboration among scientists, providers, insurers, policy makers and stakeholders to accelerate uptake of high impact HIV prevention. (3) CAPACITY BUILDING: To mentor and train researchers, policy makers, providers, community leaders and staff members in health, criminal justice, social service, and administrative systems to reach HIV prevention goals for 90-90-90 by 2020. Our efforts are conducted domestically and globally. CHIPTS is comprised of five Cores. (1) Administrative Core leads CHIPTS interdisciplinary team, convenes center meetings and coordinates science, networking and capacity building agendas at local, state, national, and international levels. It ensures financial and scientific integrity, leads strategic planning and promotes a Global HIV Prevention Strategies Program. (2) Development Core invests in innovative, early stage research, supports emerging investigators and promotes dissemination events. (3) Combination Prevention Core promotes research on combination behavioral, biomedical, technological and structural interventions to reduce HIV incidence and to improve viral suppression, especially in key populations and those with substance use and mental health disorders. (4) Methods Core guides innovation and impact in measurement, statistical methods, and implementation science, focusing on factors presented by those with substance use and mental health disorders. (5) Policy Impact Core optimizes public health impact and science implementation by providing evidence on policy options to guide HIV prevention policy.

Public Health Relevance

Los Angeles has the second highest number of AIDS cases nationally and has one of the most ethnically diverse epidemics. Exciting developments in HIV prevention science have shifted the fight against new HIV infections from a lack of available effective interventions to a lack of will. The UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) mobilizes world class leaders in the areas of science, networking and capacity building to lead the HIV prevention agenda both domestically and internationally.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH058107-24
Application #
9864087
Study Section
Special Emphasis Panel (ZMH1)
Program Officer
Gordon, Christopher M
Project Start
1997-09-30
Project End
2022-01-31
Budget Start
2020-02-01
Budget End
2021-01-31
Support Year
24
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Family Medicine
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Bristow, Claire C; Kojima, Noah; Lee, Sung-Jae et al. (2018) HIV and syphilis testing preferences among men who have sex with men and among transgender women in Lima, Peru. PLoS One 13:e0206204
Shin, S S; Modongo, C; Zetola, N M et al. (2018) High rates of exposure to tuberculosis patients among HIV-infected health care workers in Botswana. Int J Tuberc Lung Dis 22:366-370
van den Berg, Jacob J; Javanbakht, Marjan; Gorbach, Pamina M et al. (2018) Partner Notification for Youth Living With HIV in 14 Cities in the United States. J Acquir Immune Defic Syndr 77:46-52
Storholm, Erik D; Bogart, Laura M; Mutchler, Matt G et al. (2018) Antiretroviral Adherence Trajectories Among Black Americans Living with HIV. AIDS Behav :
Rotheram-Fuller, Erin J; Tomlinson, Mark; Scheffler, Aaron et al. (2018) Maternal patterns of antenatal and postnatal depressed mood and the impact on child health at 3-years postpartum. J Consult Clin Psychol 86:218-230
Antonio, Anna Liza M; Weiss, Robert E; Saigal, Christopher S et al. (2018) A Bayesian hierarchical model for discrete choice data in health care. Stat Methods Med Res 27:3544-3559
Earnshaw, Valerie A; Reisner, Sari L; Menino, David et al. (2018) Stigma-Based Bullying Interventions: A Systematic Review. Dev Rev 48:178-200
Hermanstyne, Keith A; Green Jr, Harold D; Cook, Ryan et al. (2018) Social Network Support and Decreased Risk of Seroconversion in Black MSM: Results of the BROTHERS (HPTN 061) Study. J Acquir Immune Defic Syndr 78:163-168
Salazar-Austin, N; Kulich, M; Chingono, A et al. (2018) Age-Related Differences in Socio-demographic and Behavioral Determinants of HIV Testing and Counseling in HPTN 043/NIMH Project Accept. AIDS Behav 22:569-579
Okafor, Chukwuemeka N; Christodoulou, Joan; Bantjes, Jason et al. (2018) Understanding HIV Risk Behaviors Among Young Men in South Africa: A Syndemic Approach. AIDS Behav :

Showing the most recent 10 out of 715 publications